<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>

        References<lb/> 
        <bibl><label>1</label>. Round Table Discussion. The health and economic impact of rhinitis. Am J Manag<lb/> ed to participate than those with less severe or better controlled<lb/> Care 1997; 3: S8-S18<lb/> symptoms.<lb/> Shedden<lb/> </bibl>
        <bibl><label>4</label>. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents<lb/> 19. McFadden EA, Gungor A, Ng B, et al. Loratadine/pseudoephedrine for nasal<lb/> with allergic rhinoconjunctivitis: development and testing of a questionnaire for<lb/> symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled<lb/> clinical trials. J Allergy Clin Immunol 1994; 93: 413-23<lb/> study. Ear Nose Throat J 2000; 79: 254, 257-8, 260 passim<lb/> </bibl>
        <bibl><label>5</label>. Corey JP, Houser SM, Ng BA. Nasal congestion: a review of its etiology,<lb/> 20. Nathan RA. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene<lb/> evaluation, and treatment. Ear Nose Throat J 2000; 79: 690-3, 696, 698 passim<lb/> receptor antagonists compared with other treatments. Ann Allergy Asthma<lb/> </bibl>
        <bibl><label>6</label>. Jessen M, Malm L. Definition, prevalence and development of nasal obstruction.<lb/> Immunol 2003; 90: 182-90<lb/> Allergy 1997; 52: 3-6<lb/> </bibl>
        <bibl><label>21</label>. Ratner PH, Paull BR, Findlay SR, et al. Fluticasone propionate given once daily is<lb/> </bibl>
        <bibl><label>7</label>. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Nasal obstruction in patients with<lb/> as effective for seasonal allergic rhinitis as beclomethasone dipropionate given<lb/> seasonal allergic rhinitis: relationships between allergic inflammation and nasal<lb/> twice daily. J Allergy Clin Immunol 1992; 90 (3 Pt 1): 285-91<lb/> airflow. Int Arch Allergy Immunol 2004; 134: 34-40<lb/> </bibl>
        <bibl><label>22</label>. Bronsky EA, Dockhorn RJ, Meltzer EO, et al. Fluticasone propionate aqueous<lb/> </bibl>
        <bibl><label>8</label>. Bachert C, van Kempen M, Van Cauwenberge P. Regulation of proinflammatory<lb/> nasal spray compared with terfenadine tablets in the treatment of seasonal<lb/> cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118:<lb/> allergic rhinitis. J Allergy Clin Immunol 1996; 97: 915-21<lb/> </bibl>

        375-9<lb/> 
        <bibl><label>23</label>. Welch MJ. Topical nasal steroids for allergic rhinitis. West J Med 1993; 158: 616-7<lb/> </bibl>
        <bibl><label>9</label>. Ciprandi G, Cirillo I, Klersy C, et al. Nasal obstruction is the key symptom in hay<lb/> fever patients. Otolaryngol Head Neck Surg 2005; 133: 429-35<lb/> </bibl>
        <bibl><label>24</label>. Graft D, Aaronson D, Chervinsky P, et al. A placebo-and active-controlled<lb/> </bibl>
        <bibl><label>10</label>. Naclerio R. Clinical manifestations of the release of histamine and other inflam-<lb/>randomized trial of prophylactic treatment of seasonal allergic rhinitis with<lb/> matory mediators. J Allergy Clin Immunol 1999; 103 (3 Pt 2): S382-5<lb/> mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996; 98:<lb/> 11. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered<lb/> 724-31<lb/> breathing. The University of Wisconsin Sleep and Respiratory Research Group.<lb/> 25. Hebert JR, Nolop K, Lutsky BN. Once-daily mometasone furoate aqueous nasal<lb/> J Allergy Clin Immunol 1997; 99: S757-62<lb/> spray (Nasonex) in seasonal allergic rhinitis: an active-and placebo-controlled<lb/> </bibl>
        <bibl><label>12</label>. McColley SA, Carroll JL, Curtis S, et al. High prevalence of allergic sensitization<lb/> study. Allergy 1996; 51: 569-76<lb/> in children with habitual snoring and obstructive sleep apnea. Chest 1997; 111:<lb/> 26. Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate<lb/> 170-3<lb/> (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of<lb/> </bibl>
        <bibl><label>13</label>. Kakumanu S, Glass C, Craig T. Poor sleep and daytime somnolence in allergic<lb/> perennial rhinitis. 194-079 Study Group. Ann Allergy Asthma Immunol 1997;<lb/> rhinitis: significance of nasal congestion. Am J Respir Med 2002; 1: 195-200<lb/> 79: 370-8<lb/> </bibl>
        <bibl><label>14</label>. Caprandi G, Cirillo I, Vizzaccaro A, et al. Airway function and nasal inflammation<lb/> 27. Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis<lb/> in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2004; 34: 891-6<lb/> as a cause of sleep disturbance and daytime fatigue and the response to topical<lb/> </bibl>
        <bibl><label>15</label>. Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom<lb/> nasal corticosteroids. J Allergy Clin Immunol 1998; 101: 633-7<lb/> intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin<lb/> Immunol 1995; 95 (5 Pt 2): 1084-96<lb/> </bibl>
        <bibl><label>28</label>. Storms WW. Minimal persistent inflammation, an emerging concept in the nature<lb/> and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy<lb/> </bibl>
        <bibl><label>16</label>. Rappai M, Collop N, Kemp S, et al. The nose and sleep-disordered breathing: what<lb/> we know and what we do not know. Chest 2003; 124: 2309-23<lb/> </bibl>
<bibl>Asthma Immunol 2003; 91: 131-40<lb/> </bibl>
        <bibl><label>17</label>. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg<lb/> 2004; 130: 617-29<lb/> Correspondence and offprints: Arthur Shedden, Schering-Plough Corpora-<lb/></bibl>
        <bibl><label>18</label>. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing.<lb/> tion, Kenilworth, 2000 Galloping Hill Road, NJ 07033, USA.<lb/> </bibl>
<bibl>J Allergy Clin Immunol 1997; 99: S750-6</bibl>
        </listBibl>
    </text>
</tei>

